Post by
riverrrow on May 31, 2021 10:38pm
more competition for TLT
https://au.finance.yahoo.com/news/successful-test-cancer-killing-drug-115734679.html
Comment by
DJDawg on May 31, 2021 11:15pm
Interesting article for sure. Usually when they are testing a drug on zebrafish it is fairly early in the IND enabling work. It might be competition but so many more steps to happen over many years.
Comment by
gebremeskel on Jun 01, 2021 11:27am
TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models Published online 2020 Mar 4 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139549/
Comment by
socksnblonds642 on Jun 01, 2021 12:34pm
There was more info on what a Trosian horse is than what their compound is so I think it's safe to say they are a ways off from Theralase IMO. TLD1433 results will drive everything. It doesn't matter if there are 2 or 3 or 6 other competitors. Unfortunately the market is big enough to support all solutions. Hope they all work. So we just become rich instead of stinking rich.
Comment by
Eoganacht on Jun 01, 2021 2:15pm
More detailed info : Photoactivatable metabolic warheads enable precise and safe ablation of target cells in vivo https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062536/#MOESM8
Comment by
BlueFranky on Jun 01, 2021 2:23pm
Eoganacht. Great to see you back!
Comment by
Mikee3003 on Jun 01, 2021 5:30pm
Thanks Eogan, always look forward to the informative research you provide to this board. Please keep up the great work. Thanks, Mikee